We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

In Ma we trust

14 January 2015 By Robyn Mak

The involvement of China’s richest man in a drugmaker’s share placement has sent the company’s market value up by over $1 bln. There may be synergies between e-commerce and pharmaceuticals, but details are lacking. Investors are too eager for the Jack Ma endorsement. 

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)